Manifaxine Hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameManifaxine Hydrochloride
Drug Alias Name盐酸马尼法辛1555U88GW-320659BW-1555U88
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonistsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityObesity

Other Information

ATC CodeN/A
Related LinksWikipedia